Condition: Stroke · Chronic Stroke · Intracerebral Haemorrhage · Sponsor: Johns Hopkins University
The main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.
This description comes directly from the study's public registry record.
Steven R Zeiler, M.D., Ph.D. · 303-520-7404 · sz@jhmi.edu
Victor C Urrutia, M.D. · 443-254-6435
Always discuss trial participation with your own doctor first.
| Johns Hopkins | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07053917